塞德斯医疗公布的最新数据显示,其药物安全性表现良好,与先前的研究结果保持一致。此次数据涵盖了新的450毫克负荷剂量方案,以及最高可达300毫克、每四周给药一次的维持治疗方案。
塞德斯医疗公布的最新数据显示,其药物安全性表现良好,与先前的研究结果保持一致。此次数据涵盖了新的450毫克负荷剂量方案,以及最高可达300毫克、每四周给药一次的维持治疗方案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.